NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘RA Capital’

14 January 2015

RA Capital, NEA back biopharma company Cortendo with private placement

biotech virus lab Healthcare focused RA Capital Management has joined New Enterprise Associates and Broadfin Capital in backing listed biopharmaceutical company Cortendo in a private placement deal.

28 August 2014

RA Capital, Redmile in huge $55m Series C for cancer-fighting biotech business

cancer juno RA Capital Management and Redmile Group were among 11 new investors in a $55m Series C financing round for biotech company Bellicum Pharmaceuticals.

3 April 2014

Intarcia Therapeutics scores $200m round

biotech_lrg Venture capital firm RA Capital has led a massive $200m round for biotech startup Intarcia Therapeutics.

22 January 2014

Venture capital-backed Dicerna prices IPO at $11 to $13 per share

dna Venture capital-backed RNA interference-based therapeutics developer Dicerna Pharmaceuticals has priced its IPO at $11 to $13 per share.

1 August 2013

RA Capital backs mammoth $60m Series C round for RNA Interference

dna RA Capital has helped emerging pharmaceutical company RNA Interference close an enormous $60m Series C financing round.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015